EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 107 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $104,437 | -4.8% | 13,071 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $109,681 | +196.3% | 12,607 | +0.1% | 0.00% | – |
| Q1 2023 | $37,015 | -14.3% | 12,590 | +2.0% | 0.00% | – |
| Q4 2022 | $43,187 | -55.9% | 12,339 | -0.4% | 0.00% | -100.0% |
| Q3 2022 | $98,000 | +2.1% | 12,384 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $96,000 | -36.0% | 12,209 | -1.3% | 0.00% | 0.0% |
| Q1 2022 | $150,000 | +9.5% | 12,370 | +10.2% | 0.00% | 0.0% |
| Q4 2021 | $137,000 | +14.2% | 11,228 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $120,000 | +13.2% | 11,564 | -2.3% | 0.00% | – |
| Q2 2021 | $106,000 | – | 11,839 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $50,920,000 | 12.31% |
| ACUTA CAPITAL PARTNERS, LLC | 307,944 | $3,742,000 | 1.75% |
| Samsara BioCapital, LLC | 480,000 | $5,832,000 | 1.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,909,407 | $35,349,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,666 | $2,256,000 | 0.93% |
| Altium Capital Management LP | 224,541 | $2,728,000 | 0.91% |
| RA Capital Management | 3,370,506 | $40,952,000 | 0.89% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 276,591 | $3,361,000 | 0.42% |
| MYDA Advisors LLC | 55,000 | $668,000 | 0.26% |
| Atom Investors LP | 40,855 | $496,000 | 0.23% |